Learn About Central Serous Chorioretinopathy

What is the definition of Central Serous Chorioretinopathy?
Central serous chorioretinopathy is a disease that causes fluid to build up under the retina, the back part of the inner eye that sends sight information to the brain. The fluid leaks from the choroid (the blood vessel layer under the retina). The cause of this condition is unknown but stress can be a risk factor. Signs and symptoms include dim and blurred blind spot in the center of vision, distortion of straight lines and seeing objects as smaller or farther away.
Save information for later
Sign Up
What are the alternative names for Central Serous Chorioretinopathy?
  • Central serous chorioretinopathy
  • Central serous chorioretinopathy after bone marrow transplantation
  • Central serous choroidopathy
Who are the top Central Serous Chorioretinopathy Local Doctors?
JC
Jay K. Chhablani
Dr. Jay K. Chhablani
Ophthalmology
Elite
Highly rated in
29
conditions
Ophthalmology

University of Pittsburgh Medical Center

UPMC Eye Center

203 Lothrop St, 
Pittsburgh, PA 

Jay Chhablani is an Ophthalmologist in Pittsburgh, Pennsylvania. Chhablani has been practicing medicine for over 20 years and is rated as an Elite expert by MediFind in the treatment of Central Serous Chorioretinopathy. He is also highly rated in 29 other conditions, according to our data. His top areas of expertise are Central Serous Chorioretinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), and Cataract Removal. He is licensed to treat patients in Pennsylvania. Chhablani is currently accepting new patients.

CB
Camiel J. Boon
Elite
Highly rated in
14
conditions

Amsterdam University Medica Center - Locatie AMC

Amsterdam, NL 

Camiel Boon practices in Amsterdam, Netherlands. Boon is rated as an Elite expert by MediFind in the treatment of Central Serous Chorioretinopathy. He is also highly rated in 14 other conditions, according to our data. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Stargardt Macular Degeneration, and Age-Related Macular Degeneration (ARMD).

 
 
 
 
Learn about our expert tiers
Learn more
FC
Francine F. Cohen-Behar
Elite
Highly rated in
13
conditions

Université De Paris

Inserm Umr 1138, 15, Rue De L'ecole De Médecine, 
Paris, FR 

Francine Cohen-Behar practices in Paris, France. Cohen-Behar is rated as an Elite expert by MediFind in the treatment of Central Serous Chorioretinopathy. She is also highly rated in 13 other conditions, according to our data. Her top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Cataract Removal, and Corneal Transplant.

View All Doctors
What are the latest Central Serous Chorioretinopathy Clinical Trials?
Steroid Eye Drops Versus Placebo Eye Drops in Chronic Central Serous Chorioretinopathy Trial (PICS Trial)
Enrollment Status: Not yet recruiting
Publish Date: December 01, 2022
Intervention Type: Drug
Study Phase: Phase 3

Summary: In this pilot study the effect and safety of the use of steroid eye drops in chronic central serous chorioretinopathy (cCSC) will be evaluated. The study is conducted as a randomized single-blind placebo-controlled trial. Forty patients will be randomized to either steroid eye drops or placebo eye drops. Patients will self-administer the eye drops three times a day for four weeks.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy
Enrollment Status: Recruiting
Publish Date: October 21, 2022
Intervention Type: Drug

Summary: Patients with central serous chorioretinopathy (CSC) will be monitored with laser speckle flow graphy (LSFG), swept source optical coherence tomography (SS-OCT) and SS-OCT angiography (SS-OCTA). We aim to unveil the flow and pulse wave characteristics of the choroidal circulation in acute CSC and chronic CSC.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Central Serous Chorioretinopathy?
Central Serous Chorioretinopathy in a 14-year-old atopic boy: a case report.
Condition: Central Serous Chorioretinopathy (CSC) in Atopic Boy
Journal: Italian journal of pediatrics
Treatment Used: Betamethasone Valerate and Bromfenac
Number of Patients: 1
Published: January 03, 2023
Topical Dexamethasone as an Adjuvant to Mineralocorticoid Receptor Antagonists for the Treatment of Recalcitrant Central Serous Chorioretinopathy.
Condition: Recalcitrant Central Serous Chorioretinopathy (CSCR)
Journal: Ophthalmic surgery, lasers & imaging retina
Treatment Used: Topical Dexamethasone as Adjuvant to Mineralocorticoid Receptor Antagonists
Number of Patients: 8
Published: December 22, 2022
Tired of the same old research?
Check Latest Advances
Ocular toxicity of targeted therapies with MEK inhibitors and BRAF inhibitors in the treatment of metastatic cutaneous melanoma.
Condition: Metastatic Cutaneous Melanoma
Journal: Journal francais d'ophtalmologie
Treatment Used: MEK Inhibitors and BRAF Inhibitors
Number of Patients: 27
Published: May 02, 2022
View All Latest Advances